KOVALTRY

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey

Active ingredients

The drug KOVALTRY contains one active pharmaceutical ingredient (API):

1 Octocog alfa
UNII P89DR4NY54 - ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Octocog alfa (Full length recombinant human coagulation factor VIII (rDNA)) is a purified protein that has 2,332 amino acids. It is produced by recombinant DNA technology in baby hamster kidney cells (BHK) into which the human factor VIII gene has been introduced.

Read about Octocog alfa

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
KOVALTRY Powder and solvent for solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BD02 Coagulation factor VIII B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 538920050030607, 538920050030707, 538920050030807, 538920050030907, 538920050031007
Country: CA Health Products and Food Branch Identifier(s): 02451441, 02451468, 02451476, 02451484, 02451492
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 180-MBE-0421, 185-MBE-0421, 207-MBE-0721
Country: EE Ravimiamet Identifier(s): 1713372, 1713383, 1713394, 1713406, 1713417
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1151076002, 1151076004, 1151076006, 1151076008, 1151076010
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 049119, 096660, 389337, 531926, 578050
Country: FR Base de données publique des médicaments Identifier(s): 60797807, 64966902, 65700541, 66206474, 68686890
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8168, 8169, 9305
Country: IT Agenzia del Farmaco Identifier(s): 044726014, 044726026, 044726038, 044726040, 044726053, 044726065, 044726077, 044726089, 044726091, 044726103, 044726115, 044726127, 044726139, 044726141, 044726154, 044726166, 044726178, 044726180, 044726192, 044726204, 044726216, 044726228, 044726230, 044726242
Country: JP 医薬品医療機器総合機構 Identifier(s): 6343447D1025, 6343447D2021, 6343447D3028, 6343447D4024, 6343447D5020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1079695, 1079849, 1079851, 1079853, 1079855, 1086340, 1086341, 1086342, 1089283, 1089284, 1089285, 1089286, 1089287, 1089288, 1089289, 1089290
Country: NL Z-Index G-Standaard, PRK Identifier(s): 57673, 57681, 57703, 85731
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18739, 18754, 18756, 18757, 18758
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100367045, 100367051, 100367068, 100367074, 100367080
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64713001, W64714001, W64715001, W64716001
Country: SG Health Sciences Authority Identifier(s): 15586P, 15587P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699546790074, 8699546790081, 8699546790098, 8699546790104, 8699546790111

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.